Table 2. Baselines of laboratory test values.
| Parameters | Non-AKI (n=512) | AKI (n=71) | Z | P |
|---|---|---|---|---|
| ALB (g/L) | 42 [39–44] | 43 [39–45] | 0.9068 | 0.3645 |
| ALP (U/L) | 74 [62–93] | 81 [71–98] | 2.015 | 0.0439 |
| ALT (U/L) | 33 [22–44] | 33 [26–41] | 0.1472 | 0.883 |
| AST (U/L) | 30 [23–42] | 30 [25–41] | 0.0004 | 0.9997 |
| GGT (U/L) | 24.5 [16–43.5] | 24 [18–40] | 0.1759 | 0.8604 |
| Hb (g/L) | 135 [122–147] | 134 [122–145] | −0.1571 | 0.8751 |
| WBC (×109/L) | 10.44 (7.62–14.38) | 10.59 (7.49–14.81) | 0.1869 | 0.8518 |
| PLT (×109/L) | 207 (168.5–258) | 180 (147.5–226) | −3.2057 | 0.0013 |
| L% | 9.6 (5.85–16.3) | 8.85 (5.8–15.2) | −1.0739 | 0.2829 |
| N% | 84.7 (76.2–89.5) | 85.95 (77.75–89.6) | 1.1545 | 0.2483 |
| TBIL (μmol/L) | 15.1 (11.95–21.7) | 17.1 (11.8–21.3) | 0.6794 | 0.4969 |
| PT (s) | 11.1 (10.5–11.8) | 10.9 (10.4–12.4) | 0.1486 | 0.8819 |
| PT-INR | 1.01 (0.96–1.08) | 1 (0.95–1.13) | 0.143 | 0.8863 |
| APTT (s) | 28.5 (26.4–31.35) | 28.6 (26.5–31.4) | −0.1174 | 0.9066 |
| TT (s) | 19.1 (17.8–20.4) | 19.15 (18.1–20.5) | 0.4431 | 0.6577 |
| FIB (g/L) | 3.04 (2.55–3.67) | 3.37 (2.86–3.8) | 1.8829 | 0.0597 |
| D-Dimer (ng/mL) | 1,371 [459–5,825] | 1,102.5 [537–4,812] | 0.0319 | 0.9745 |
| Na+ (mmol/L) | 140 [138–142] | 140 [138–143] | 0.2625 | 0.7929 |
| K+ (mmol/L) | 3.7 (3.4–4) | 3.6 (3.2–3.9) | −2.2212 | 0.0263 |
Data are shown as median (quartile). AKI, acute kidney injury; ALB, albumin; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; GGT, gamma-glutamyl transpeptidase; Hb, hemoglobin; WBC, white blood cell; PLT, platelet; L%, percentage of lymphocytes; N%, percentage of neutrophil granulocyte; TBIL, total bilirubin; PT, prothrombin time; INR, international normalized ratio; APTT, activated partial thromboplastin time; TT, thrombin time; FIB, fibrinogen; Na+, sodium concentration; K+, potassium concentration.